Tuesday, November 10, 2015

Shasun Pharma

Changes in S&P BSE Indices
 
Content
India, Mumbai, Tuesday Nov 10, 2015 - With reference to Notice no: 20151109-43, owing 
to amalgamation of Shasun Pharmaceuticals Ltd (Stock Code - 524552) with Strides
 Arcolab Ltd., Shasun Pharmaceuticals will be discontinued from trading effective 
November 18, 2015 which necessitates its exclusion from various indices.

Indices
Drop
Add
EFFECTIVE FROM

CODE
NAME
CODE
NAME
FFF

S&P BSE AllCap
524552
Shasun Pharmaceuticals Ltd.
--
--
--
18-Nov-2015
S&P BSE 500
524552
Shasun Pharmaceuticals Ltd.
532659
IDFC Ltd.
0.84
S&P BSE Healthcare
524552
Shasun Pharmaceuticals Ltd.
--
--
--
S&P BSE MidSmallCap
524552
Shasun Pharmaceuticals Ltd.
--
--
--
S&P BSE SmallCap
524552
Shasun Pharmaceuticals Ltd.
--
--
--


For any information / clarification, you may contact Index Services on +91 22 2272 5261. You can also write us at index_services@spdji.com

ASIA INDEX PRIVATE LIMITED

Asia Index Pvt. Ltd is a 50-50 partnership between S&P Dow Jones Indices LLC, the world  s largest provider of financial market indices, and BSE Ltd, Asia  s oldest stock exchange and home to the iconic SENSEX index - a leading indicator of Indian equity market performance. Asia Index Pvt. Ltd, which combines the benchmarks, market intelligence, and insights of both parent companies, each established more than 115 years ago, aims to provide a full array of indices enabling global and domestic investors to participate in South Asia  s vibrant economies. The Company is best known for calculating, publishing, and maintaining a diverse family of Asian indices under the umbrella brand, S&P BSE Indices.

Print this post

No comments: